194 related articles for article (PubMed ID: 26376365)
1. A secretory leukocyte protease inhibitor variant with improved activity against lung infection.
Camper N; Glasgow AM; Osbourn M; Quinn DJ; Small DM; McLean DT; Lundy FT; Elborn JS; McNally P; Ingram RJ; Weldon S; Taggart CC
Mucosal Immunol; 2016 May; 9(3):669-76. PubMed ID: 26376365
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
[TBL] [Abstract][Full Text] [Related]
3. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.
Sullivan AL; Dafforn T; Hiemstra PS; Stockley RA
Respir Res; 2008 Aug; 9(1):60. PubMed ID: 18699987
[TBL] [Abstract][Full Text] [Related]
5. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
6. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.
Jin F; Nathan CF; Radzioch D; Ding A
Infect Immun; 1998 Jun; 66(6):2447-52. PubMed ID: 9596701
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the developmental competence of the early embryo using secretory leukocyte peptidase inhibitor.
Kim HS; Ha KS; Kwon HC; Lee SJ; Kim CH; Cheon YP
Differentiation; 2016; 92(1-2):24-34. PubMed ID: 26927923
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection.
Peñaloza HF; Olonisakin TF; Bain WG; Qu Y; van der Geest R; Zupetic J; Hulver M; Xiong Z; Newstead MW; Zou C; Alder JK; Ybe JA; Standiford TJ; Lee JS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824208
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
[TBL] [Abstract][Full Text] [Related]
12. Working from within: how secretory leukocyte protease inhibitor regulates the expression of pro-inflammatory genes.
Douglas TC; Hannila SS
Biochem Cell Biol; 2022 Feb; 100(1):1-8. PubMed ID: 34555292
[TBL] [Abstract][Full Text] [Related]
13. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
[TBL] [Abstract][Full Text] [Related]
14. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
15. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
Sagel SD; Sontag MK; Accurso FJ
Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
[TBL] [Abstract][Full Text] [Related]
17. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
18. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
Yang J; Zhu J; Sun D; Ding A
Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.
Novak T; Fortune F; Bergmeier L; Khan I; Hagi-Pavli E
Clin Exp Immunol; 2020 Oct; 202(1):93-105. PubMed ID: 32580239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]